|
24 Jan 2007 |
Commencement of Pollinex(R) Quattro Grass Dosing.
|
|
23 Jan 2007 |
Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX(R) Immunotherapy for Pancreatic Cancer
|
|
20 Jan 2007 |
BioMS Medical Cleared By FDA To Initiate Pivotal Phase III Multiple Sclerosis Trial
|
|
19 Jan 2007 |
GlaxoSmithKline initiates head-to-head study of cervical cancer vaccines
|
|
18 Jan 2007 |
Acambis receives Complete Response Letter from FDA on ACAM2000 Biologics Licence Application
|
|
18 Jan 2007 |
First Malaria Vaccine Trial Launched Under GenVec/U.S. Navy Collaboration
|
|
17 Jan 2007 |
Novavax and Collaborators Significantly Improve VLP Vaccine for HIV/AIDS
|
|
17 Jan 2007 |
Dendreon's PROVENGE Granted FDA Priority Review for the Treatment of Asymptomatic, Metastatic, Androgen-Independent Prostate Cancer
|
|
12 Jan 2007 |
Curalogic has started clinical phase II trial with its grass product
|
|
09 Jan 2007 |
FDA Approves MedImmune's Refrigerated Formulation of FluMist(R)
|
|
09 Jan 2007 |
Dynavax Reports Interim TOLAMBA(TM) Ragweed Allergy Results From DARTT Trial
|
|
05 Jan 2007 |
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
|
|
04 Jan 2007 |
Bavarian Nordic A/S receives approval to start Phase I/II trials with breast cancer vaccine
|
|
03 Jan 2007 |
Stimuvax(R) Phase III clinical trial in patients with non-small cell lung cancer now open for patient enrollment
|
